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INTRODUCTION 
 
The circadian clock is a universal time keeping system 
that generates 24-hr rhythms in behavior and 
physiology. The activity of the circadian system is 
important for synchronization of metabolic processes 
within an organism and between an organism and its 
environment [1,2]. The importance of this coordination 
for human health is supported by a number of epide-
miological studies demonstrating that the risk of many  
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diseases, including cardiovascular disease and cancer, is 
significantly increased among shift workers; however, 
the exact mechanisms linking circadian desynchroniza-
tion and the development of various pathological 
conditions remains largely unknown [3]. At the 
molecular level the activity of the circadian clock is 
controlled by several interlocked transcription/transla-
tion feedback loops formed by the core circadian 
proteins [4,5]. Mice with a targeted disruption of 
different circadian proteins lose rhythmic patterns of 
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Abstract: Deficiency of the circadian clock protein BMAL1 leads to premature aging and increased levels of reactivate
oxygen species in several tissues of mice. In order to investigate the role of oxidative stress in accelerated aging and
development  of  age‐related  pathologies,  we  continuously  administered  the  antioxidant  N‐acetyl‐L‐cysteine  to  Bmal1‐
deficient mice through their entire lifespan by supplementing drinking water. We found that the life long treatment with
antioxidant significantly increased average and maximal lifespan and reduced the rate of age‐dependent weight loss and
development of cataracts. At the same time, it had no effect on time of onset and severity of other age‐related pathologies
characteristic of Bmal1‐/‐ mice, such as joint ossification, reduced hair regrowth and sarcopenia. We conclude that chronic
oxidative stress affects longevity and contributes to the development of at least some age‐associated pathology, although
ROS‐independent mechanisms may also play a role. Our bioinformatics analysis identified the presence of a conservative E
box element in the promoter regions of several genes encoding major antioxidant enzymes. We speculate that BMAL1
controls antioxidant defense by regulating the expression of major antioxidant enzymes.  
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abnormalities [3,6].  Recently, a connection between the 
circadian clock and aging has been established. It is 
most prominently manifested in mice deficient in the 
BMAL1 protein. During the normal course of their life, 
these animals develop multiple pathological changes 
that are characteristic of premature aging [7]. This is in 
sharp contrast to other circadian mutant mice models, 
such as Clock/Clock  and  Per2
m/m  animals, which 
accelerate their aging program and develop phenotypes 
that are reminiscent of those in Bmal1-deficient mice 
only after being exposed to a low dose of ionizing 
radiation [8,9].  
 
BMAL1 is a basic helix-loop-helix (bHLH)-PAS 
domain transcription factor and a key component of 
the circadian clock [10]. Deficiency in the BMAL1 
protein results in disruption of rhythmicity in behavior 
and gene expression pattern [11]. BMAL1 is involved 
in the control of tissue homeostasis by the direct 
regulation of reactive oxygen species (ROS); 
accordingly, its deficiency is associated with the 
excessive production of ROS resulting in chronic 
oxidative stress [7]. Many life-threatening diseases, 
including cardiovascular disease, cancer and diabetes, 
have been linked to chronic oxidative stress [12]. It 
has also been proposed that oxidative stress plays an 
important role in the development of age-associated 
pathology [13,14]; however, many aspects regarding 
its exact role in the process of aging are still under 
debate [15].  
 
Previously we have shown that age-related 
degenerative processes in several tissues of Bmal1-/- 
mice are correlated with an age-dependent increase in 
the level of ROS [7]. If excessive production of ROS 
and increased oxidative stress contribute to the early 
aging phenotype in Bmal1-/- mice, then the reduction 
of oxidative stress by antioxidants might prevent early 
aging or ameliorate its severity. This strategy has been 
previously successfully used to delay ROS-initiated 
degenerative processes in nematode, fly and mouse 
[16].  Among available antioxidants, a potent low 
molecular weight (LMW) antioxidant N-acetyl-L-
cysteine (NAC) was proved to be efficient in mice; 
indeed, treatment with NAC significantly delayed 
tumorigenesis in p53-/- mice [17] and ameliorate age-
related pathological changes induced by the deficiency 
of transcription factor FOXO [18]. Here we confirm 
the role of chronic oxidative stress in early onset of 
aging in Bmal1-/- mice. We show that continuous 
administration of NAC delays the onset of aging and 
extends the lifespan of Bmal1-deficient mice. We 
speculate that BMAL1 controls antioxidant defense by  
 
regulating the expression of major antioxidant 
enzymes.  
 
RESULTS 
  
NAC slows age-dependent body weight loss in 
BMAL1-deficient mice 
 
To investigate the effect of antioxidants on age-
dependent weight loss in BMAL1-deficient mice, we 
started treating the experimental animals from the time 
of their prenatal development by supplementing 
drinking water of the breeders with NAC. To generate 
age-matched control animals, similar breeding pairs, 
which were set up simultaneously, received regular 
water. The prolonged administration of NAC had no 
effect on the size of litters born or on the survival of 
pups during lactation. After weaning, the animals in the 
experimental group received water supplemented with 
NAC through their entire lifespan.  
 
We started monitoring the body weight of wild type 
(WT) and Bmal1-/- mice from 4 weeks of age. The 
administration of NAC slows down age-dependent body 
weight gain in mice of both genotypes (Figure 1A,B). 
Thus, by the time the body weight of WT mice 
normally reaches its maximum (30 weeks of age) and 
stabilizes, animals receiving NAC weigh ~18% less 
than their littermates raised on regular water (Figure 
1A). Similarly, until reaching their maximal weight (at 
18 weeks), Bmal1-deficient mice that received NAC 
weigh less than the corresponding control animals 
drinking regular water (23.6+0.84 and 21.15+0.55 g 
respectively, Figure 1B, p<0.01). To test whether this 
effect could be attributed to taste preferences, we 
measured daily levels of water consumption in both 
groups of WT mice and in fact determined that mice 
that receive NAC drink significantly less water (Figure 
1C). To account for these differences in consumption, 
we compared the effect of NAC on the relative weight 
of BMAL1-deficient animals (measured at each time 
point as % of the body weight of WT mice of the same 
group (Figure 1D). As shown in Figure 1D, starting 
from 25 weeks of age, when Bmal1-/- mice normally 
begin losing weight [7], animals raised on NAC-
supplemented water have significantly higher relative 
weight than animals in the control group that received 
regular water. As a result, at 40 weeks of age Bmal1-/- 
mice in the control group lost on average 20% of their 
maximal body weight; whereas the body weight of 
animals that received NAC was reduced by 4%.  Thus, 
treatment with the LMW antioxidant NAC significantly 
delayed age-dependent weight loss in BMAL1-deficient 
mice.    
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Effect of NAC on development of the phenotype of 
premature aging in Bmal1-/- mice. 
 
Previously we have demonstrated that the deficiency of 
BMAL1 is associated with an early onset of several 
phenotypes associated with normal aging [7]. Among 
those are reduced hair regrowth after shaving, 
development of cataracts, cornea inflammation, 
sarcopenia and joint ossification. This prompted us to 
test whether the administration of NAC affects the onset 
and/or severity of these changes. 
 
One of the most striking age-dependent changes related 
to deficiency in BMAL1 is the early onset of various 
eye pathologies, such as cataracts and cornea 
inflammation [7]. At 30 weeks of age, Bmal1-/- animals  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Continuous administration of NAC affects age‐dependent changes
in body weight.  Total body weight of male (A) WT and (B) Bmal1‐/‐ mice, closed
circles – control mice raised on regular water; open circles – mice raised on water
supplemented  with  40mM  of  NAC.  (C)  Relative  water  consumption  by  WT  mice
receiving either regular (closed bar) or NAC‐supplemented (open bar) water. (D) Age‐
dependent changes in relative body weight in Bmal1‐/‐ mice measured at each time
point as the percentage of the body weight of WT mice of the same group.    
 
 
 
 
 
in both groups start showing various degrees of eye 
pathologies with a slightly higher incidence in the 
control group (30% versus 15% in NAC-receiving 
animals). The difference between the two groups 
increased with age; 80% of 45-week old control mice 
developed cataracts on one or both eyes, whereas in the 
NAC-treated group only 25% of animals were affected 
(Figure 2A).  
 
The comparison of the two groups for the severity of 
other hallmarks of aging did not reveal any significant 
differences. Thus, the administration of NAC did not 
improve reduced hair regrowth characteristic of BMAL1-
deficient mice: only 3 out of 10 NAC-treated mice de-
monstrated partial or complete hair regrowth after shav-
ing, which was not different from controls (4 out of 10).  
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Treatment with NAC had no effect on the development 
of joint ossification evaluated by changes in ankle joint 
flexibility and physical performance.  The latter was 
estimated by measuring righting reflex time (the time 
required for mice to return to their normal position after 
being placed on the back).  Whereas young WT and 
Bmal1-/- mice normally take less than 1 sec, up to 3 sec 
was required for 30-week old Bmal1-/- mice, regardless 
of NAC supplementation.  
 
In order to estimate the effect of antioxidants on the 
aging of muscles, we measured grip strength by 
monitoring the ability of mice in both groups to 
maintain weight on the inverted grid. Performance of 
WT mice in this task did not change during their 
lifespan, whereas in Bmal1-/- mice it was gradually 
reduced with age (Figure 2B). However, administration 
of NAC did not improve the age-related decrease in 
muscle strength. Thus, administration of the LMW 
antioxidant NAC significantly delayed age-related 
development of cataracts,  but had no effect on manifesta- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effects of continuous administration of NAC on development of eye pathology
and muscle strength. (A) Frequency of cataracts in 30‐week old and 45‐week old Bmal1‐/‐ mice
raised on regular (closed bars) or NAC‐supplemented (open bars) water. Each eye was counted
independently; the percentage of cataracts was determined by dividing the number of cataracts by
the total number of eyes, if an animal was dead at the time of observation, then the previous score
for this animal was used. (B) Age‐dependent changes in muscular strength of WT (green bars) and
Bmal1‐/‐  mice  receiving  regular  (black  bars)  or  NAC‐supplemented  (red  bars)  water.  Muscular
strength was evaluated as the ability of animals of indicated age to maintain their weight on the
inverted grid. Each animal was tested five times, if the animal did not fall down for 30 sec the trial
was  counted  as  successful.  The  percentage  of  successful  trials  was  calculated  and  plotted.  No
difference was detected between NAC‐treated and control Bmal1‐/‐ animals. 
 
 
 
 
 
 
tion of other pathological changes in Bmal1-/- mice 
associated with premature aging.   
 
Continuous administration of NAC extends lifespan 
of Bmal1-/- mice 
 
Consistent with our previous report, Bmal1-deficient 
mice in the control group had a very short average 
lifespan of 38+11 weeks. As shown in Figure 3, 
continuous administration of NAC extends the lifespan 
to 47+12 weeks (p<0.05 Log-Rank Test). The survival 
curve for NAC-treated mice was significantly shifted, 
with 90% survival at the age of 36 weeks (only 50% of 
animals survived until this age in the control group).   
Treatment with the antioxidant also significantly affects 
the maximum lifespan, extending it from 58 weeks in 
the control group to 66 weeks in the NAC-treated 
group. All wild type mice in both the control and NAC-
treated groups survived until the termination of the 
experiment (70 weeks). Thus, treatment with a dietary 
antioxidant increases the average lifespan in Bmal1-
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by 14%.  
 
Genes encoding major antioxidant enzymes are 
potential targets of the CLOCK/BMAL1 transcrip-
tional complex 
 
Our current and previous results led us to the hypothesis 
that BMAL1 may be involved in the control of an 
organism’s response to oxidative stress and antioxidant 
defense. Antioxidant defense is controlled by a complex 
system of LMW antioxidants and antioxidant enzymes 
[12]. As a transcription factor working in complex with 
CLOCK or NPAS2, BMAL1 may regulate the activity 
of major antioxidant enzymes (MAE) at the trans-
criptional level. CLOCK/BMAL1 and NPAS2/ BMAL1 
complexes specifically bind promoters containing 
circadian E box in their regulatory regions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two circadian E box elements have been identified: 
CACGTG and CACGTT [19].   To test if any of the 
MAE genes can be directly regulated by the major 
circadian transactivation complex, we performed in 
silico analysis of their promoter regions for the presence 
of BMAL1-responsive elements. Nucleotide sequences 
covering the region between -2000bp/+ and 2000bp 
(relative to the position of the transcriptional start site) 
of the NCBI database were analyzed using EditSeq and 
MegAlign software (DNASTAR, Inc.). The results of 
the analysis summarized in Table 1 indicate that many 
of the MAE genes may in fact be directly regulated by 
the CLOCK/BMAL1 transcriptional complex.  Most 
strikingly, the position of the BMAL1-responsive 
elements in the promoters of several MAE genes such 
as Gpx1, Prdx1, Prdx6, and Sesn2 is conservative 
among primates and rodents, indicating their potential 
functional significance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Position of the circadian E‐box elements in the promoter regions (+/‐ 2000 nucleotides from major 
transcription starting site) of genes encoding major antioxidant enzymes. 
 
  Homo Sapiens  Pan Troglodites  Macaca Mulatta  Mus Musculus Rattus  Norvegicus 
SOD1  -886  -1055  -1044  -631, 768, 1787  -1661, -685, 743, 1749 
SOD2  none n/a  n/a none  none 
SOD3  -1673 n/a  n/a none  none 
GPX1  -19 -23 -93  -1196, -908, 
-54, 12  -82 
GPX2  974 n/a n/a  1263  72 
GPX3  979  1068  1061    -570, 1268   -1507, 198, 921 
GPX4   -385  n/a  n/a  -1669  none 
GPX6  173 n/a n/a  -617,  -168,  1580  none 
CAT  -1751  none  413   46, 1437     -969, 47, 1434 
PRDX1  372  none  407   218, 528   -1413, -1402, 198 
PRDX2  none n/a  n/a none  none 
PRDX3  -136 -142 -148 428   406,  1733 
PRDX4  none n/a  n/a none  none 
PRDX5  -836  n/a  n/a    -1019, -282  none 
PRDX6  -290, 991  -852, 474  -229, 1048  -159, -114, 264, 
904  -185, -140, 248 
SESN1  345, 1089  464  1095  1390  none 
SESN2  -728  none  -1549, -733  -292, -776  -759 
TXNRD1   -260  n/a  n/a  1510   -841, 170, 975 
 
SOD ‐ Superoxide dismutase; CAT – catalase;  GPX ‐ glutathione peroxidase;  
PRDX – peroxiredoxin; TXNRD ‐ thioredoxin reductase; SESN ‐ sestrin 
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DISCUSSION 
 
The free-radicals theory of aging postulates that 
oxidative damage to biological macromolecules 
produced by ROS and RNS play an important role in 
the aging process [13,14,20]. This theory is supported 
by the large amount of experimental data demonstrating 
a direct correlation between the resistance to oxidative 
stress and the lifespan in different organisms [16,21]. 
However, this theory was recently challenged by 
contradictory data obtained in various mouse models 
demonstrating that although the overexpression of 
several antioxidant enzymes makes mice more resistant 
to oxidative challenge, it fails to increase their lifespan. 
Thus, the deficiency of superoxide dismutase reduced 
the lifespan in mice, whereas the deficiency of other 
antioxidant enzymes had no effect [22]. At the same 
time, targeted overexpression of catalase in mito-
chondria results both in reduced oxidative damage in 
tissues of transgenic mice and an increased lifespan 
[23]. Such conflicting data may arise from the fact that 
laboratory mice are normally maintained under optimal 
husbandry conditions, their antioxidant defense is well 
balanced and works efficiently in protecting from 
relatively low levels of ROS, therefore overexpression 
of antioxidant enzymes has a marginal effect. At the 
same time, the disruption of the antioxidant defense will 
have a more dramatic effect on the lifespan and may  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.  Continuous  administration  of NAC  increases  lifespan of  Bmal1‐/‐
mice.  Kaplan‐Meyer  survival  curves  were  obtained  for  WT  mice  raised  on  regular
(closed circles) or NAC‐supplemented (open circles) water; and Bmal1‐/‐ mice raised on
regular (closed triangles) or NAC‐supplemented (open triangles) water. NAC significantly
increased lifespan of Bmal1‐/‐ mice (P =0.022, log‐rank Mantel‐Haenszel test).  
 
 
 
 
significantly contribute to the development of age-
associated pathologies.   
 
ROS and RNS are produced in the organisms either as 
side products of metabolic reaction or by a specific 
group of enzymes. ROS and RNS serve as important 
mediators of intra- and extra- cellular signaling and 
many physiological processes are regulated by specific 
species [12].  An excessive amount of ROS results in 
damage to biological macromolecules, which is known 
as oxidative stress and is an essential contributor to the 
development of such diseases as cancer, diabetes and 
cardiovascular diseases [12]. Therefore, ROS and RNS 
levels are tightly controlled at both intra- and extra-
cellular levels by antioxidant systems. Previously we 
have demonstrated that accelerated aging of Bmal1- 
deficient mice is associated with an age-dependent 
increase in the level of ROS in different tissue [7]. The 
fact that an increase in ROS concentration was detected 
in those tissues that demonstrate pathological changes 
may suggest that the early onset of aging in Bmal1-
deficient mice is caused by excessive production and/or 
insufficient detoxification of ROS.  Here we show that 
continuous administration of antioxidant NAC can 
significantly ameliorate the onset and severity of 
premature aging in Bmal1-deficient mice. Thus, de-
regulation of ROS homeostasis in fact contributes 
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by the deficiency of the BMAL1 protein.  
 
Noteworthy, treatment of Bmal1-/- mice with NAC 
cannot completely prevent premature aging; growth 
retardation, reduced hair regrowth, sarcopenia, and joint 
ossification were not affected by administration of 
NAC. There are two possible explanations for the 
incomplete rescue. First, NAC treatment may not be 
efficient enough due to tissue-specific differences in its 
distribution, which may restrict the antioxidant effect to 
a particular tissue. Second, BMAL1 may be involved in 
the control of aging through both ROS- dependent and 
ROS-independent mechanisms. However, administra-
tion of NAC attenuated the development of the most 
prominent age-related phenotype of Bmal1-/- mice, 
development of cataracts, and even most importantly, 
significantly extended the average and maximal lifespan 
of Bmal1-/- mice.  
 
BMAL1 is a transcription factor critical for circadian 
function. In complex with its dimerization partners, 
CLOCK or NPAS2, BMAL1 controls the expression of 
several clock genes and multiple clock-controlled genes 
(CCGs). Based on microarray data, the about 10% of all 
transcripts display daily oscillations in expression, 
indicating that they may be clock-regulated [24]. The 
results of the bioinformatics analysis of the promoter 
regions of several genes encoding major antioxidant 
enzymes reveal the presence of conservative circadian E 
box elements, suggesting that at least some of the genes 
encoding antioxidant enzymes can be CCGs. 
Importantly, potential targets of BMAL1 include 
antioxidant enzymes, which control different stages of 
ROS detoxification. Among those are superoxide 
dismutase that converts superoxide into hydrogen 
peroxide; catalase, peroxiredoxines and glutathione 
peroxidase that reduce hydrogen peroxide and sestrins 
that are key regulators of oxidized peroxiredoxins 
reduction. Therefore, by controlling different steps of 
the process, the CLOCK/BMAL1 transcriptional 
complex may orchestrate the entire chain of 
reduction/oxidation reactions, which are necessary for 
the efficient detoxification of ROS.   
 
The importance of circadian orchestration of antioxidant 
defense is supported by the fact that the disruption of 
this control results in oxidative stress leading to various 
pathological developments. Supporting this hypothesis 
are epidemiological data on disease spectra in shift 
workers. It is documented that disturbance of the 
circadian system through shift work or frequent travel 
across time zones leads to increased risk of cardio-
vascular diseases, diabetes and cancer. Although the 
molecular pathways responsible for this link are mostly 
unknown [25-27], it is well accepted that oxidative 
stress is one of the major causes in pathophysiology of 
these diseases. We speculate that when BMAL1-
dependent circadian control of the antioxidant defense 
of an organism is disrupted by shift work, it leads to 
oxidative stress and increases risk of disease.  
 
In summary, we demonstrated that treatment with the 
LMW antioxidant NAC delivered as a dietary 
supplement ameliorated the aging of BMAL1 deficient 
mice. These results suggest that an increased level of 
ROS is involved in the development of accelerating 
aging in this animal model. BMAL1 may control the 
ROS level through regulation of expression of major 
antioxidant enzymes, some of which are potential 
transcriptional targets of the CLOCK/BMAL1 complex. 
While circadian control of ROS homeostasis is critical 
for aging, some other oxidative stress independent 
mechanisms may also be involved. 
 
EXPERIMENTAL PROCEDURES 
 
Animals.  Bmal1-/-  mice that were originally obtained 
from Dr. Bradfield (University of Wisconsin) were 
backcrossed to C57BL/6J mice for 12 generations. The 
colony was maintained as a heterozygous intercross to 
obtain animals of all three genotypes. Mice were 
genotyped by PCR as previously described [11]. All 
animals were maintained on a 12 h:12 h light:dark cycle 
in standard plastic cages and lifespan was determined 
by recording the age at spontaneous death. Animals 
treated with the antioxidant received 40mM NAC in 
drinking water during their entire life, starting from 
prenatal development (breeding pairs were maintained 
on NAC); water bottles were changed once every three 
days.  To monitor body weight gain/loss, animals were 
weighed once a week. Mice were observed daily for the 
general health status and to score mortality. Each group 
was represented by 10 animals. 
 
Hair regrowth assay. Was performed on 30-week old 
mice as previously described [7]. Dorsal segments of 
skin were shaved and animals were monitored for hair 
regrowth for 3 months.  
 
Estimation the muscle strength. Animals were placed on 
a wire cage top, which then was gently flipped over. 
Each animal was tested in five trials; a trial, in which 
animal did not fall down for 30 sec was scored as 
successful and the percentage of successful trials was 
calculated.  
 
Righting reflex. Mouse was turned over onto its back 
and the time necessary to return back to a normal 
position (i.e. to right itself onto all four feet) was 
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for each mouse. 
 
Detection of cataracts. Eye opacity was evaluated and 
scored under bright light by two independent 
experienced observers, who were blind to treatment and 
genotype. Every eye was counted independently; 
therefore the percentage was determined by dividing the 
number of cataracts by the total number of affected 
eyes. If an animal was dead at the time of observation, 
the previous score was added to the total number. 
Cataracts of different severity were score equally. All 
animal studies were conducted in accordance with the 
regulations of the Committees of Animal Care and Use 
at the Cleveland Clinic Foundation, Cleveland State 
University and Roswell Park Cancer Institute.  
 
Statistical analyses. All statistical analyses were 
performed using SigmaStat 3.5 software (Systat 
Software, Inc., CA). Lifespan curves were calculated 
using Kaplan-Meier survival analysis; the statistical 
significance of curves was assessed using log-rank 
Mantel-Haenszel tests. P values <0.05 were considered 
as significant; the median, mean, and maximum 
survivals were calculated for each group.  
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